THz Waves – A New Potential Treatment for Alzheimer’s Disease

Glowing Brain

Amyloid deposition, a hallmark of diseases like Alzheimer’s and Parkinson’s, follows a sigmoidal curve where misfolded proteins form oligomers before fibril elongation. Researchers have developed a technique using a specific THz frequency to regulate this deposition, showing the potential to delay amyloid fibrillation.

Amyloid deposition is a hallmark of neurodegenerative disorders like Alzheimer’s disease (AD) and Parkinson’s disease (PD). This accumulation process follows a sigmoidal pattern where misfolded proteins first gather into oligomers before expanding into fibrils. Throughout this transformation, misfolded monomers that initially have more of an α-helix configuration transition into a predominant crosslinked β-sheet structure. Addressing this harmful buildup could offer a potential approach to delay or even prevent the onset of these diseases.

In a new paper published in eLight, a team of scientists led by Professor Chao Chang from Peking University have developed a unique technique that uses a specific frequency to regulate and minimize the development of amyloid deposition.

It was conjectured in 2018 that the physical field of biological neural signals might be a high-frequency electromagnetic field ranging from terahertz (THz) to infrared (IR). It is most likely to range from 0.5 to 100 THz and is named a generalized THz electromagnetic (EM) wave. Some physiological processes have been proved, such as the unwinding of DNA hairpins, the permeability of the voltage-gated calcium channel, and the currents of voltage-gated K+ can regulate that.

The mechanism revealed that the THz wave resonates with the molecular population and modifies the hydrogen bond (H-bond) formed therein. Moreover, it was reported that the intermolecular H-bond network that parallels the fibril axis is the key to leading the amyloid fibrils.

Inspired by these, it would be essential to prevent or mitigate AD pathology if resonant features could be exploited to modulate the self-assembly process and avoid undesired protein aggregation. An earlier study found that a 1675cm-1 (50.25 THz) light could dissociate the amyloid fibrils by a joint free-electron laser experiment and molecular dynamics (MD) simulation method.

Schematic of Potential Alzheimer’s Treatment Using High Frequency Terahertz Radiation

a)The presence of extracellular β-amyloid deposition as neuritic plaques and the intracellular accumulation of hyperphosphorylated tau as neuro fibrillary tangles remain the primary neuropathologic features for AD diagnosis, and the amyloid deposition begins with the conversion of native monomers with more α-helices to an alternative conformation with β-sheet that self-associate into ordered assemblies. b) A terahertz (THz) wave at a frequency of 34.88 THz delays the fibrosis dynamic curve. c) The wave decreased the aggregation speed to 80% of the case without the wave. d) The wave promotes cell proliferation. e The wave loosens the dense protein conformation with transformed β-sheets to a structure with more coil and bend regions. Credit: Wenyu Peng, Zhi Zhu, Jing Lou, Kun Chen, Yuanming Wu, Chao Chang

There was a significant thermal effect at this frequency because the biological liquid has a strong absorption at the range of 45-52.5 THz. It results in the regulated efficiency in the physiological environment being bound to be considerably weakened. Therefore, exploring nonthermal and efficient methods to inhibit the Aβ aggregation process is urgent.

The research team used amyloid β (Aβ) as an example to conduct the research. It does not claim that Aβ plays the determining role in AD development, so more and more research has begun to emphasize the significance of tau protein. Amyloid proteins have similar dynamic aggregation processes. There are still no effective drugs that can inhibit or alleviate the deterioration of AD pathology.

The study intended to regulate the conformations of pathological proteins by optical means that intervene in the dynamic process. This research based on Aβ may be further applied to tau protein, which is of great significance for developing combination therapy.

The research team used the quantum cascade laser (QCL) with a central frequency of 34.88 THz (8.6 µm) to irradiate the Aβ1-42 oligomers. They monitored the fibrosis process by Thioflavin T (ThT) binding assay and Fourier transform infrared (FTIR) spectrometer. The research team found that the fibrosis process has been slowed down significantly compared to the group without an external field. The safety of this frequency on the cell level has also been detected through cell viability and mitochondrial membrane potential assays.

It can be seen that the cells proliferated significantly, and there was a slight increase in mitochondrial membrane potential. It demonstrates that the THz waves may positively affect the cells’ function. The research team also found a significant change in protein conformation, which presents from the regularly ordered structure to a disordered structure, specifically, with more β-sheet structure transformed to the coil and bend region. THz waves may be a promising strategy to delay the amyloid fibrillation process.

Reference: “High-frequency terahertz waves disrupt Alzheimer’s β-amyloid fibril formation” by Wenyu Peng, Zhi Zhu, Jing Lou, Kun Chen, Yuanming Wu and Chao Chang, 1 August 2023, eLight.
DOI: 10.1186/s43593-023-00048-0

The study was funded by the National Natural Science Foundation of China, the key innovative project in Shaanxi, and the Shanghai Rising-Star Program.

Be the first to comment on "THz Waves – A New Potential Treatment for Alzheimer’s Disease"

Leave a comment

Email address is optional. If provided, your email will not be published or shared.